Long-term ECMO, efficiency and performance of EUROSETS adult A.L.ONE ECMO oxygenator.
Efficiency
Extracorporeal membrane oxygenator
Hollow fibers
Long term
Performance
Polymethylpentene
Safety
Journal
Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113
Informations de publication
Date de publication:
30 Mar 2023
30 Mar 2023
Historique:
received:
12
01
2023
accepted:
26
03
2023
medline:
3
4
2023
entrez:
30
3
2023
pubmed:
31
3
2023
Statut:
epublish
Résumé
The management of the oxygenator can be prolonged in the long-term procedures especially during extracorporeal membrane oxygenation (ECMO) for bridge to transplant or bridge to recovery. Long-term use often involves an overrun of the time of use with respect to certification of the oxygenating module of 14 days, for the maintenance of performance and efficiency of the oxygenator. The evaluation of the long-term oxygenator efficiency is complex and depends on the: patient pathology, ECMO configuration, the management of coagulation and anticoagulation, materials selection and circuit components, the structure, design and performance of the oxygenator. In this context we investgated the long-term performance of the A.L.ONE Eurosets ECMO oxygenator in relation to the parameters prodromal to replacement. We retrospectively collected eight years data from Anthea Hospital GVM Care & Research, Bari, Italy on the long-term use exceeding 14 days of Eurosets A.L.ONE ECMO Adult oxygenator in Polymetylpentene fiber, for ECMO procedures, including the procedures: Veno Arterial (VA) ECMO post-cardiotomy or not, veno-venous (VV) ECMO. The primary end points were the evaluation of Gas Transfer: oxygen partial pressure (PO Nine VA ECMO patients who used the oxygenator for 18.5 days and two VV ECMO patients who used the oxygenators for 17.2 days on the seventeenth days reported average values PaO The performance of the Eurosets A.L.ONE ECMO Adult polymethylpentene fiber oxygenator in our experience has proven efficiency in terms of O
Sections du résumé
BACKGROUND
BACKGROUND
The management of the oxygenator can be prolonged in the long-term procedures especially during extracorporeal membrane oxygenation (ECMO) for bridge to transplant or bridge to recovery. Long-term use often involves an overrun of the time of use with respect to certification of the oxygenating module of 14 days, for the maintenance of performance and efficiency of the oxygenator. The evaluation of the long-term oxygenator efficiency is complex and depends on the: patient pathology, ECMO configuration, the management of coagulation and anticoagulation, materials selection and circuit components, the structure, design and performance of the oxygenator. In this context we investgated the long-term performance of the A.L.ONE Eurosets ECMO oxygenator in relation to the parameters prodromal to replacement.
METHODS
METHODS
We retrospectively collected eight years data from Anthea Hospital GVM Care & Research, Bari, Italy on the long-term use exceeding 14 days of Eurosets A.L.ONE ECMO Adult oxygenator in Polymetylpentene fiber, for ECMO procedures, including the procedures: Veno Arterial (VA) ECMO post-cardiotomy or not, veno-venous (VV) ECMO. The primary end points were the evaluation of Gas Transfer: oxygen partial pressure (PO
RESULTS
RESULTS
Nine VA ECMO patients who used the oxygenator for 18.5 days and two VV ECMO patients who used the oxygenators for 17.2 days on the seventeenth days reported average values PaO
CONCLUSIONS
CONCLUSIONS
The performance of the Eurosets A.L.ONE ECMO Adult polymethylpentene fiber oxygenator in our experience has proven efficiency in terms of O
Identifiants
pubmed: 36998079
doi: 10.1186/s13019-023-02190-9
pii: 10.1186/s13019-023-02190-9
pmc: PMC10061787
doi:
Substances chimiques
Carbon Dioxide
142M471B3J
Oxygen
S88TT14065
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
95Informations de copyright
© 2023. The Author(s).
Références
Int J Artif Organs. 2016 Jun 15;39(4):200-4
pubmed: 27323916
J Cardiothorac Surg. 2022 Mar 17;17(1):38
pubmed: 35300722
Front Med (Lausanne). 2018 Dec 12;5:352
pubmed: 30619862
Crit Care. 2020 Nov 30;24(1):671
pubmed: 33256824
ASAIO J. 2014 Nov-Dec;60(6):652-6
pubmed: 25158889
J Thorac Dis. 2018 Mar;10(Suppl 5):S596-S605
pubmed: 29732176
ASAIO J. 2008 Nov-Dec;54(6):612-7
pubmed: 19033775
Perfusion. 2020 May;35(1_suppl):29-33
pubmed: 32397880
PLoS One. 2014 Dec 02;9(12):e112316
pubmed: 25464516
ASAIO J. 2020 Jul;66(7):825-833
pubmed: 31567421